In line, necrostatin‐1, an anti‐necroptotic molecule, was found to ameliorate cognitive impairment in AD models through targeting Aβ and tau proteins plus alleviating brain cell death (Yang et al. 2017). The gene discussed is MAPT; the disease is Cognitive impairment.